Caspofungin versus liposomal amphotericin B for empirical therapy - Reply

被引：0
|
作者：
Walsh, TJ [1 ]
Donowitz, GR
dePauw, BE
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] Univ Virginia Hlth Syst, Charlottesville, VA 22908 USA
[3] Univ Hosp St Radboud, NL-6525 GA Nijmegen, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [1] Caspofungin versus liposomal amphotericin B for empirical therapy
    Kontoyiannis, DP
    Lewis, RE
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04): : 410 - 410
  • [2] Caspofungin Versus Liposomal Amphotericin B Are They Really Comparable? Reply
    Walsh, Thomas J.
    Maertens, Johan A.
    Madero, Luis
    Reilly, Anne F.
    Lehrnbecher, Thomas
    Groll, Andreas H.
    Jafri, Hasan S.
    Green, Michael
    Nania, Joseph J.
    Bourque, Michael R.
    Wise, Beth Ann
    Strohmaier, Kim M.
    Taylor, Arlene F.
    Kartsonis, Nicholas A.
    Chow, Joseph W.
    Arndt, Carola A. S.
    dePauw, Ben E.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (10) : 986 - 987
  • [3] Voriconazole versus liposomal amphotericin B for empirical antifungal therapy - Reply
    Walsh, TJ
    Pappas, PG
    Winston, DJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22): : 1746 - 1747
  • [4] Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
    Walsh, TJ
    Teppler, H
    Donowitz, GR
    Maertens, JA
    Baden, LR
    Dmoszynska, A
    Cornely, OA
    Bourque, MR
    Lupinacci, RJ
    Sable, CA
    dePauw, BE
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14): : 1391 - 1402
  • [5] Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever
    Wingard, John R.
    Leather, Helen L.
    Wood, Craig A.
    Gerth, William C.
    Lupinacci, Robert J.
    Berger, Marc L.
    Mansley, Edward C.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (06) : 637 - 643
  • [6] Caspofungin Versus Liposomal Amphotericin B Are They Really Comparable?
    Sekine, Leo
    Humbwavali, Joao
    Wolff, Fernando Herz
    Barcellos, Nemora Tregnago
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (10) : 985 - 986
  • [7] ECONOMIC EVALUATION OF CASPOFUNGIN VERSUS LIPOSOMAL AMPHOTERICIN B FOR EMPIRICAL ANTIFUNGAL THERAPY IN PATIENTS WITH PERSISTENT FEVER AND NEUTROPENIA IN SWEDEN
    Lundberg, J.
    Naik, S.
    Kumar, R.
    Sjolin, J.
    Jansen, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 194 - 194
  • [8] Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden
    Naik, Shalini
    Lundberg, Johan
    Kumar, Ritesh
    Sjolin, Jan
    Jansen, Jeroen P.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (6-7) : 504 - 514
  • [9] Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia
    Al-Badriyeh, Daoud
    Liew, Danny
    Stewart, Kay
    Kong, David C. M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1276 - 1285
  • [10] Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis
    Bocanegra, R
    Najvar, LK
    Hernandez, S
    McCarthy, DI
    Graybill, JR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) : 5139 - 5141
12345